AtralCipan

AtralCipan is a prominent Portuguese pharmaceutical group that integrates the capabilities of Laboratórios Atral and Cipan to provide end-to-end solutions in drug development and manufacturing. The company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms, with a globally recognized expertise in antibiotics produced via fermentation and chemical synthesis. Operating as a full-service CDMO, AtralCipan serves both the human and veterinary medicine markets, exporting products to over 50 countries. Their portfolio includes a wide range of generic medicines and specialized antibiotic compounds such as tetracyclines. With extensive manufacturing facilities in Portugal, the group is a critical partner in the global pharmaceutical supply chain, maintaining high standards of quality and regulatory compliance.